Screening of compounds to identify novel epigenetic regulatory factors that affect innate immune memory in macrophages

Sci Rep. 2022 Feb 3;12(1):1912. doi: 10.1038/s41598-022-05929-x.

Abstract

Trained immunity and tolerance are part of the innate immune memory that allow innate immune cells to differentially respond to a second encounter with stimuli by enhancing or suppressing responses. In trained immunity, treatment of macrophages with β-glucan (BG) facilitates the production of proinflammatory cytokines upon lipopolysaccharide (LPS) stimulation. For the tolerance response, LPS stimulation leads to suppressed inflammatory responses during subsequent LPS exposure. Epigenetic reprogramming plays crucial roles in both phenomena, which are tightly associated with metabolic flux. In this study, we performed a screening of an epigenetics compound library that affects trained immunity or LPS tolerance in macrophages using TNFα as a readout. Among the 181 compounds tested, one compound showed suppressive effects, while 2 compounds showed promoting effects on BG-trained TNFα production. In contrast, various inhibitors targeting Aurora kinase, histone methyltransferase, histone demethylase, histone deacetylase and DNA methyltransferase showed inhibitory activity against LPS tolerance. Several proteins previously unknown to be involved in innate immune memory, such as MGMT, Aurora kinase, LSD1 and PRMT5, were revealed. Protein network analysis revealed that the trained immunity targets are linked via Trp53, while LPS tolerance targets form three clusters of histone-modifying enzymes, cell division and base-excision repair. In trained immunity, the histone lysine methyltransferase SETD7 was identified, and its expression was increased during BG treatment. Level of the histone lysine demethylase, LSD1, increased during LPS priming and siRNA-mediated reduction resulted in increased expression of Il1b in LPS tolerance. Taken together, this screening approach confirmed the importance of epigenetic modifications in innate immune memory and provided potential novel targets for intervention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation
  • Cells, Cultured
  • Epigenesis, Genetic / drug effects*
  • Female
  • Histone Demethylases / genetics
  • Histone Demethylases / metabolism
  • Histone-Lysine N-Methyltransferase / genetics
  • Histone-Lysine N-Methyltransferase / metabolism
  • Immune Tolerance / drug effects*
  • Immunity, Innate / drug effects*
  • Immunologic Memory / drug effects*
  • Immunomodulating Agents / pharmacology*
  • Interleukin-1beta / genetics
  • Interleukin-1beta / metabolism
  • Lipopolysaccharides / immunology
  • Lipopolysaccharides / pharmacology
  • Macrophage Activation / drug effects*
  • Macrophages / drug effects*
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Protein Interaction Maps
  • Tumor Necrosis Factor-alpha / metabolism
  • beta-Glucans / immunology
  • beta-Glucans / pharmacology

Substances

  • IL1B protein, mouse
  • Immunomodulating Agents
  • Interleukin-1beta
  • Lipopolysaccharides
  • Tnf protein, mouse
  • Tumor Necrosis Factor-alpha
  • beta-Glucans
  • Histone Demethylases
  • KDM1a protein, mouse
  • Histone-Lysine N-Methyltransferase
  • Setd7 protein, mouse